NCT05410938View on ClinicalTrials.gov

Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
Interventions
DRUG

Chemotherapy

Triweekly chemotherapy with bevacizumab versus intraperitoneal chemotherapy without bevacizumab

Trial Locations (1)

22050

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER